The initial diagnostic approach of aggressive peripheral B-cell lymphomas should include the evaluation of the morphological and immunophenotypic characteristics including, as previously discussed, the COO and the percentage of MYC and BCL2-positive neoplastic cells. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.